Clinical Trials Contact

About this Clinical Trial

Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies

Your Message Will Go To

Juliana Craig

650-736-0912


All fields are required. *

Preferred contact method*

To:

Juliana Craig

650-736-0912



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine